Upload
kim
View
212
Download
0
Embed Size (px)
Citation preview
SPECIAL ARTICLE
Nonpharmacological Management ofApathy in Dementia: A Systematic Review
Henry Brodaty, M.B.B.S., M.D., D.Sc., F.R.A.C.P., F.R.A.N.Z.C.P.,Kim Burns, B.Psych. (Hons.)
Apathy is one of the most challenging and prevalent behavioral symptoms of de-mentia. It is associated with increased disability and caregiver frustration as wellas reduced quality of life, rehabilitation outcomes and survival after nursing homeadmission. A literature search to set criteria yielded 56 nonpharmacological inter-vention studies with outcomes relevant to apathy in dementia. Studies were ratedaccording to quality and categorized into 7 groups: exercise, music, multisensory, an-imals, special care programming, therapeutic activities and miscellaneous. Despite alack of methodological rigor, it is apparent that nonpharmacological interventionshave the potential to reduce apathy. This review indicates that therapeutic activities,particularly those provided individually, have the best available evidence for effec-tiveness in dementia. Recommendations are provided for quality research. (Am JGeriatr Psychiatry 2012; 20:549–564)
Key Words: Abulia, amotivation, apathy, nonpharmacological, passivity, psychosocial
A pathy represents a form of executive cognitivedysfunction,1 which overlaps with other psy-
chological and behavioral aspects such as mood, per-sonality, and cognitive functioning.2 Definitions tendto emphasize diminished reward and goal-directedbehaviors.3 Apathy can describe an internal state oflack of interest or a state of behavioral inaction.4 Theapathy spectrum includes reduced initiative, inter-est, motivation, spontaneity, affection, energy, enthu-siasm, emotion, and persistence as well as bluntedaffect.5,6 The nosology of apathy is blurred, and ithas received little attention in the scientific literaturein spite of its prevalence.7–9 Synonyms for apathy in-
Received June 25, 2010; revised January 31, 2011; accepted February 25, 2011. From the Academic Department for Old Age Psychiatry(ADfOAP), Prince of Wales Hospital (HB, KB); and Dementia Collaborative Research Centre, Faculty of Medicine, School of Psychiatry,University of New South Wales (HB), Randwick, New South Wales, Australia. Send correspondence and reprint requests to Professor HenryBrodaty, Dementia Collaborative Research Centre, AGSM, UNSW, Sydney, NSW 2052, Australia. e-mail: [email protected]. Supple-mental digital content is available for this article. Direct URL citations appear in the printed text and is provided in the HTML and PDFversions of this article on the journal’s Web site (www.AJGPonline.org).
C© 2012 American Association for Geriatric PsychiatryDOI: 10.1097/JGP.0b013e31822be242
clude passivity, abulia, and amotivation. Apathy canbe a symptom of many neuropsychiatric disordersor a syndrome per se.10,11 At a symptomatic level,Marin12 defines apathy as “loss of motivation due todisturbance of intellect, emotion or level of conscious-ness” and at syndromal level as primary motivationalloss or “loss of motivation not attributable to emo-tional distress, intellectual impairment or diminishedlevel of consciousness.” Individuals with apathy “doless, think less and feel less.”13 Stuss et al.14 proposesthree subtypes of apathy: emotional, cognitive, andbehavioral defined on the basis of the anatomical re-gions and psychological mechanisms involved.
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 549
Nonpharmacological Management of Apathy in Dementia
DIFFERENTIAL DIAGNOSIS
Diagnostic criteria for apathy were initially pro-posed by Marin.12,15 Lack of motivation is evidencedby diminished goal-directed behavior, goal-directedcognition, and emotion, relative to previous function-ing levels and not attributable to intellectual impair-ment, emotional distress, or diminished conscious-ness. Emotional distress is absent. These criteria havebeen adapted over time.16,17 Recent modificationspropose that diminished motivation must be presentmost of the time for at least 4 weeks and a minimumof one symptom should be evident from two of thebehavioral, cognitive, and emotional domains.18,19 Inaddition, symptoms should cause clinically signifi-cant functional impairment and not be attributableto physical disabilities, motor disabilities, or directphysiological effects of a substance.
Apathy is related to but distinct from depres-sion5,20–25 and dysphoria.1,26,27 Although there isan overlap in symptoms, individuals with apathypresent as compliant or passive, whereas those withdepression are deliberately avoidant.15 Further evi-dence of the distinction between apathy and depres-sion is the stronger association between degree ofapathy and degree of cognitive impairment, particu-larly in executive functioning, than in depression.3,28
Assessment of apathy in dementia is further com-plicated by the need to distinguish between dimin-ished behavior due to loss of motivation and lossof ability secondary to cognitive impairment.7,15 Theuse of antipsychotic, antidepressant, and neurolepticmedications, which can induce side effects such asfatigue, lethargy, listlessness, and reduced responseto stimuli, can initiate, maintain, or imitate apatheticbehaviors.29
FREQUENCY
Apathy has been associated with neurological, psy-chiatric, medical, drug-induced, and socioenviron-mental conditions.30 The frequency of apathy in neu-rological disorders ranges from 0% to 92%3 with thehighest prevalence reported in progressive supranu-clear palsy,31–34 frontotemporal dementia,35–38 andsevere Alzheimer disease (AD).39 The commonestcauses of clinically significant apathy are dementia
and schizophrenia.3 Our focus is on dementia, inwhich apathy is one of the most challenging, preva-lent, and persistent behavioral symptoms,1,25,27,40–54
particularly the subcortical dementias. In studies us-ing the Neuropsychiatric Inventory,55 a structuredcaregiver interview to assess the frequency and sever-ity of specific behaviors in dementia, apathy occurredin up to 70% of patients with AD.13,24,56–58
Apathy is a major clinical feature of demen-tia with subcortical and frontal pathology suchas dementia with Lewy bodies,59–61 Huntington’sdisease,33,62–66 Binswanger’s disease,67,68 and vascu-lar dementia.50,69 Apathy in AD has also been signifi-cantly related to older age and depression.25 Rates ofapathy in Parkinson’s disease range between 16.5%and 51%70–76 and following stroke between 22.5%and 27%.22,77–80 AD with a stroke prior to onset isalso associated with an increased risk of apathy.81 Ap-athy following a cerebrovascular event has been as-sociated with older age and right fronto-subcorticalpathway pathology.22 In mild cognitive impairment,apathy occurs in between 11.1%82 and 39.8%42,83,84 ofcases, which is intermediate between rates in elderlynormal controls and AD85,86 and predicts a higherrate of conversion to AD.82–84,87–89
Discrepancies in the frequency of estimates of apa-thy in neuropsychiatric conditions may be attributedto a lack of standardized diagnostic criteria58,90 andassessment methods.7,17,91 Furthermore, apathy maybe underreported because as a negative symptom, itis more difficult for family caregivers to identify andquantify in comparison to other behavioral symp-toms of dementia.1
Effects of Apathy
Apathy is associated with increased disability andfrustration as well as decreased quality of life in pa-tients and caregivers alike.92 Families not recogniz-ing an apathetic state may become increasingly re-sentful as they misperceive the patient as lazy.11,93–95
The potential for apathy to prevent patients seek-ing assistance, to be misdiagnosed with depressionor to become noncompliant with treatment furtherexacerbates the degree of dysfunction.93 Apathy issignificantly related to reduced independence in ac-tivities of daily living,28,96,97 survival duration afternursing home admission,98 and poor outcomes inrehabilitation.86,99
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
550 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and Burns
Patients with apathy may retain capacity but notself-initiative and hence may undertake activities ingroups that they are unable to do alone.77 Morbidityand mortality may also be indirectly related to ap-athy as residents in long-term care tend to be lessnoticed by care staff and receive fewer direct carehours.29,75 In addition, behavioral deficits influencestaff-resident interactions and quality of care100 aswell as staff distress, frustration, and job satisfaction.
In summary, apathy has significant consequencesand is common in neurological disorders, with thehighest prevalence occurring in people with de-mentia. While studies of its measurement, preva-lence, and etiology are increasing, management hasbeen largely neglected. Recognized guidelines for themanagement of apathy do not exist.101 Reports on theoutcomes of interventions are scattered among vari-ous diagnoses, and the evaluation of outcomes is dif-ficult and unwieldy. The focus of this review is anevaluation of the psychosocial interventions for ap-athy in dementia.
METHOD
A systematic search of MEDLINE (1950–2009),PsycINFO, EMBASE (1980–2009), Cochrane LibraryDatabase (2005–2009), Psycbite (2004–2009), andCINAHL was undertaken. The search terms apathy,abulia, amotivation, and passivity were combinedwith each of the following: nonpharmacological,psychological or psychosocial as well as demen-tia, AD, vascular dementia, multi-infarct dementia,frontotemporal dementia, Pick’s disease, subcorticaldementia, Lewy body dementia, or Binswanger’s dis-ease. This yielded a total of 156 potentially rele-vant papers, which were screened. Reference listsof relevant articles were hand searched and MeSHterms checked. Due to the limited number of stud-ies located, outcomes related to apathy in dementiawere also accepted. These include participation, in-terest, accepting invitations, curiosity, perseverance,engagement, self-initiative, motivation, interactionwith others, doing activities, pursuing involvement,and emotional responsiveness.
Articles were considered for inclusion if theywere available in English and full text. Studiesmet criteria if they included more than five partic-ipants with a diagnosis related to dementia and a
comparison group. All care settings were eligible.Where two or more articles based on similar stud-ies by the same authors were available, the betteror best study was selected for inclusion. This deci-sion was made according to the most recent, mostrelevant to apathy, and/or most complete study orthose with a greater number of participants. Arti-cles were excluded where studies comprised five orfewer participants;102–108 no comparison data wereprovided;93,109 another paper from the same researchgroup was included;96,110–115 participant group in-cluded other psychiatric disorders116 or individu-als without dementia;117 and/or outcomes relevantto apathy were not provided separately118–124 orquantitatively.119
To establish rater reliablility, two reviewers inde-pendently rated the methodological quality of 10studies according to criteria compiled by the au-thors and based on published guidelines.125–128 Thekappa measure of agreement indicated substantialagreement between the raters (0.76). Studies werejudged to be of good quality if they reached an ar-bitrary cut off score of 11/15, as outlined in ourcompanion paper.129 In addition, the National Healthand Medical Research Council (NHMRC) evidencehierarchy126,130,131 was used to determine levels of ev-idence for each intervention group. See companionpaper for a description.
RESULTS
Fifty-six studies met criteria for inclusion(see Tables, Supplemental Digital Content 1–7,http://links.lww.com/AJGP/A21, which outlineall studies meeting inclusion criteria). Studies weregrouped into broad categories with therapeuticactivities (see Table, Supplemental Digital Con-tent 6, http://links.lww.com/AJGP/A21, whichoutlines therapeutic activity interventions) incor-porating the greatest number followed by music(see Table, Supplemental Digital Content 2,http://links.lww.com/AJGP/A21, which outlinesmusic interventions). Research was primarily con-ducted in residential or hospital settings withnine studies incorporating community dwellers.Studies of purely community dwellers were rep-resented in the therapeutic activities132–135 andthe miscellaneous interventions136,137 groups only
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 551
Nonpharmacological Management of Apathy in Dementia
(see Table, Supplemental Digital Content 7,http://links.lww.com/AJGP/A21, which outlinesmiscellaneous interventions), while the music138 andmultisensory139,140 groups (see Table, SupplementalDigital Content 3, http://links.lww.com/AJGP/A21,which outlines multisensory interventions) includedstudies which incorporated some community par-ticipants. Even then, many of the interventionsprovided to participants living in the communitywere delivered during attendance at day care orday hospital settings. Articles largely report researchwith positive or partially positive results with only10 studies reporting nonsignificant results. Durationof intervention ranged from single episode to 18months with five studies of 1 year or longer. Twenty-three studies report interventions lasting 4 weeks orless; four studies do not report the time frame.
The majority of studies (29/56) employed a within-subject design. While many studies included acomparison group or condition, when NHMRCguidelines for a randomized controlled trial (RCT)are applied only eight studies met criteria. A fur-ther 16 report randomization of participants yet themethod is not stated, unclear, or inadequate to con-ceal group allocation and are hence classified as pseu-dorandomized. Blinded ratings are reported in onlyeight studies while another seven indicate partialblinding. The majority of studies (47/56) indicatedthat participants were diagnosed using standardizedcriteria; however, in remaining studies, the diagnos-tic criteria were unclear, not stated, or inadequate.Sustainability of effects was typically not reported;seven studies included a follow-up period; and onlytwo of those reported follow-up data for 6 months orlonger. Statistical comparisons were frequently mul-tiple; however, only 12 studies adjusted for these.Sixteen studies included intention-to-treat analysesand six studies omitted statistical significance. Apa-thy was typically not a primary outcome of the in-cluded studies and specific apathy data were mostlyunavailable for treatment and/or control groups toenable effect sizes to be calculated. These limitationsinevitably affect the validity of reported outcomes.
Our quality ratings for accepted studies rangedfrom 2 to 13 out of a possible 15. Table 1 outlinesstudies that met criteria for an RCT or a quality rat-ing of 11 or higher. When studies were grouped byyear of publication or type of intervention, no pat-tern of increasing participant numbers or quality over
time emerged. The therapeutic activities category hadthe greatest number of higher quality studies (4 witha rating of 11 or better). This group includes an ar-ray of different intervention types as well as the morenovel approaches with greater emphasis on individ-ually tailored interventions. No other link was foundbetween intervention types and quality of studies orpositive outcomes.
Participant numbers were characteristically smallwith only 18 studies reporting 60 participants or moreat recruitment and only 16 providing evidence of suf-ficient power. When grouped by intervention type,therapeutic activities included the greatest number ofparticipants with a combined total of 712. Clearly, in-terventions for groups of participants yield highernumbers, yet the multisensory category reached anoverall total of 374 participants using interventionsfor individuals only. Twenty studies in all, primarilyfrom the multisensory and therapeutic interventiongroups, were administered to individuals; a furtherfive studies included interventions for both groupsand individuals while the majority reported group in-terventions. Of the studies delivered individually, 17were tailored for individual interests and/or skills, ofwhich 15 reported a positive or partially positive out-come. Eight of the nine nontailored, but individuallydelivered studies, reported a positive or partially pos-itive outcome.
Music therapies make up the largest homogenousgroup with 11 studies. Of these, only one met our cri-teria for quality research and none met criteria forRCTs although two studies included a control condi-tion. All trials were conducted in residential settings,and one study also incorporated day hospital atten-dees.
Table 2 summarizes the included studies,as rated according to NHMRC evidencehierarchy.126,130,131 Of the three exercise interventionstudies, two present nonsignificant outcomes, in-cluding one high-quality RCT at level II. All but oneof the 11 music studies show positive results; how-ever, no RCTs are included. Only two studies meetcriteria for level III-1 evidence, while the majority areranked at level III-3. Multisensory stimulation stud-ies include one RCT, with a nonsignificant outcome,ranked at level II. The remainder are ranked at levelIII-3 or lower although all have positive results. Allseven studies of animal interventions had positiveoutcomes, but none ranked above III-3 due to a
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
552 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and BurnsT
AB
LE1.
RC
Ts
An
d/O
rH
igh
erQ
ual
ity
Stu
die
so
fP
sych
oso
cial
Inte
rven
tio
ns
for
Ap
ath
y
Stu
dy
Inte
rven
tio
ns
Stu
dy
Des
ign
Fo
llo
w-u
pN
um
ber
Met
ho
do
fR
and
om
izat
ion
Bli
nd
ing
of
Rat
ers
Ou
tco
mes
Rel
evan
tto
Ap
ath
ySi
gnifi
can
ceQ
ual
ity
Rat
ing
Exer
cise
Co
ttet
al.,
2002
,C
anad
a141
Wal
k-an
d-t
alk
sess
ion
s,i.e
.,co
nve
rsat
ion
wh
ilew
alki
ng
inp
airs
vers
us
talk
-on
lyse
ssio
ns,
i.e.,
con
vers
atio
nw
hile
sitt
ing
inp
airs
;bo
thgr
ou
pse
ssio
ns
for
30m
inu
tes,
5×
wee
kly
for
16w
eeks
vers
us
usu
alp
rogr
am
Clu
ster
edR
CT
.N
of/
u86
ITT
and
74IA
resi
den
tsw
ith
AD
in3
geri
atri
clo
ng-
term
care
faci
litie
s(3
9fe
mal
es)
Res
iden
tsra
nd
om
lyas
sign
edto
gro
up
wit
hin
each
site
wit
hra
nd
om
nu
mb
erta
ble
.No
furt
her
det
ails
of
allo
cati
on
pro
vid
ed
Rat
ers
blin
ded
togr
ou
pm
emb
ersh
ipb
ut
no
tst
ud
yd
esig
n
Enga
gem
ent,
hel
pin
gb
ehav
ior,
and
rela
tio
nsh
ips
wit
ho
ther
sas
mea
sure
db
yth
ed
isen
gage
men
tsu
bsc
ale
of
the
Lon
do
nP
sych
oge
riat
ric
Rat
ing
Scal
e142
,143
;so
cial
com
mu
nic
atio
nan
do
vera
llco
mm
un
icat
ion
asm
easu
red
by
the
Fun
ctio
nal
Ass
essm
ent
of
Co
mm
un
icat
ion
Skill
sfo
rA
du
lts14
4
No
sign
ifica
nt
bet
wee
n-g
rou
pd
iffe
ren
ces
fou
nd
on
ou
tco
me
mea
sure
sat
po
stte
stfo
rw
alk-
and
-tal
kse
ssio
ns.
Gro
up
and
leve
lof
cogn
itiv
eim
pai
rmen
tex
amin
edas
bet
wee
n-s
ub
ject
fact
ors
.Mai
nef
fect
for
gro
up
no
tsi
gnifi
can
tb
ut
mai
nef
fect
for
cogn
itiv
eim
pai
rmen
tsi
gnifi
can
tfo
rco
mm
un
icat
ion
inth
ose
wit
hm
od
erat
eim
pai
rmen
t(F
[1,6
8]=
44.6
5,p
=0.
00).
Gro
up
×co
gnit
ive
imp
airm
ent
inte
ract
ion
no
tsi
gnifi
can
t.
12
Mu
sic
Ho
lmes
etal
.,20
06,
Un
ited
Kin
gdo
m14
5Live
inte
ract
ive
mu
sic
ther
apy
vers
us
pre
reco
rded
mu
sic
sess
ion
sve
rsu
ssi
len
ced
uri
ng
1×
1.5
ho
ur
sess
ion
con
sist
ing
of
30-m
inu
tep
erio
dfo
rea
chco
nd
itio
n
Inte
rru
pte
dti
me
seri
esw
ith
ou
tp
aral
lelc
on
tro
lgr
ou
p.N
of/
u
32N
Hre
sid
ents
wit
hm
od
erat
eto
seve
red
emen
tia
(28
fem
ales
)
Ord
ero
fsi
len
cean
dm
usi
calp
erio
ds
ran
do
miz
ed.
Met
ho
dn
ot
stat
ed
Blin
ded
ind
epen
den
t,o
bse
rver
-ra
ters
Red
uce
dap
ath
yth
rou
ghp
osi
tive
enga
gem
ent
asm
easu
red
by
dem
enti
aca
rem
app
ing,
beh
avio
rca
tego
ryco
des
146
,147
acco
rdin
gto
vid
eore
cord
ings
rate
dat
3-m
inu
tein
terv
als
by
atr
ain
ed,
ind
epen
den
tra
ter
Po
siti
veen
gage
men
td
uri
ng
live
mu
sic
sess
ion
sw
assi
gnifi
can
tly
grea
ter
than
du
rin
gp
rere
cord
edm
usi
c(p
<0.
01)
and
sile
nt
(p<
0.00
)se
ssio
ns;
po
siti
veen
gage
men
td
uri
ng
pre
reco
rded
mu
sic
was
no
tsi
gnifi
can
tly
grea
ter
than
du
rin
gsi
len
tp
erio
ds.
13
Mu
ltis
enso
ryB
aker
etal
.,20
03,
Un
ited
Kin
gdo
m,
Net
her
-la
nd
s,an
dSw
eden
139
MSS
vers
us
con
tro
lac
tivi
tyd
uri
ng
30-m
inu
tese
ssio
ns
twic
ew
eekl
yo
ver
4w
eeks
RC
T.F
/u,1
mo
nth
po
sttr
eatm
ent
136
ITT
and
127
IAo
lder
adu
lts
wit
hd
emen
tia
(94
com
mu
nit
yd
wel
ling
and
42p
sy-
cho
geri
atri
cin
pat
ien
ts);
inte
rven
tio
ngr
ou
pN
=65
,co
ntr
ol
gro
up
N=
71
Co
mp
ute
rra
nd
om
izat
ion
wit
hep
idem
iolo
gyso
ftw
are
No
Ap
ath
ysu
bsc
ale
of
the
BR
Sse
ctio
no
fth
eC
lifto
nA
sses
smen
tP
roce
du
res
for
the
Eld
erly
,148
,149
apat
het
ic/
wit
hd
raw
nsu
bsc
ale
of
the
Beh
avio
ur
and
Mo
od
Dis
turb
ance
Scal
e,15
0,1
51
no
nso
cial
beh
avio
rsu
bsc
ale
of
the
GIP
152
,153
asw
ella
ssp
on
tan
eity
,in
itia
tive
,an
din
acti
vity
asra
ted
wit
hth
e“I
nte
ract
”fo
rmd
evel
op
edb
yth
eau
tho
rs.13
9
No
sign
ifica
nt
dif
fere
nce
sb
etw
een
MSS
and
con
tro
lact
ivit
ygr
ou
ps
fro
mb
efo
reto
afte
rse
ssio
ns.
Sign
ifica
nt
mai
nef
fect
so
fti
me.
Bo
thgr
ou
ps
rela
ted
bet
ter
too
ther
s(F
[1,1
08]=
28.9
7,p
<0.
0001
)an
dw
ere
less
bo
red
/in
acti
ve(F
[1,1
08]=
43.3
8,p
<0.
0001
)af
ter
sess
ion
sw
hen
com
par
edw
ith
bef
ore
.T
he
seve
rely
cogn
itiv
ely
imp
aire
din
the
MSS
gro
up
wer
esi
gnifi
can
tly
less
apat
het
ico
nth
eB
RS
apat
hy
sub
scal
eaf
ter
sess
ion
sw
hen
com
par
edw
ith
bef
ore
(F[1
,83]
=7.
20,p
<0.
01).
Imp
rove
men
th
add
eter
iora
ted
atfo
llow
-up
.
12
(Con
tin
ued
)
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 553
Nonpharmacological Management of Apathy in Dementia
TA
BLE
1.
(Co
nti
nu
ed)
Stu
dy
Inte
rven
tio
ns
Stu
dy
Des
ign
Fo
llo
w-u
pN
um
ber
Met
ho
do
fR
an-
do
miz
atio
nB
lin
din
go
fR
ater
sO
utc
om
esR
elev
ant
toA
pat
hy
Sign
ifica
nce
Qu
alit
yR
atin
g
Spec
ialc
are
pro
gram
min
gB
elle
lliet
al.,
1998
,Ita
ly15
4Sp
ecifi
cally
des
ign
edSC
Ud
emen
tia
pro
gram
ove
r6
mo
nth
s
Inte
rru
pte
dti
me
seri
esw
ith
ou
tp
aral
lelc
on
tro
lgr
ou
p.N
of/
u
55p
atie
nts
wit
hm
od
erat
eto
seve
red
emen
tia
and
seve
reb
ehav
iora
ld
istu
rban
ces
in8
SCU
s(4
3fe
mal
es)
Res
iden
tsad
mit
ted
con
secu
tive
lyto
the
SCU
sfr
om
wai
tin
glis
t.P
arti
cip
ants
serv
edas
thei
ro
wn
con
tro
ls
No
Ap
ath
yas
mea
sure
db
yth
eN
PI55
Sign
ifica
nt
red
uct
ion
inap
ath
yb
etw
een
adm
issi
on
(M=
5.6,
SD=
5.1)
and
3-m
on
ths
(M=
3.3,
SD=
3.8
p=
0.00
5),
wh
ich
was
mai
nta
ined
at6-
mo
nth
s(M
=3.
3,SD
=3.
7,p
=0.
014)
.
11
Law
ton
etal
.,19
98,U
nit
edSt
ates
155
Stim
ula
tio
n-
retr
eat
mo
del
of
care
(co
mb
ined
staf
ftr
ain
ing,
inte
rdis
ci-
plin
ary
care
pla
nn
ing,
acti
vity
pro
gram
min
g,an
dfa
mily
sup
po
rt)
vers
us
usu
alca
reo
ver
12m
on
ths
Clu
ster
edR
CT
.No
f/u
182
ITT
and
97IA
NH
resi
den
tsw
ith
mo
der
ate
tose
vere
dem
enti
ain
2SC
Us
(14
fem
ales
);in
terv
enti
on
gro
up
N=
88,
con
tro
lgro
up
N=
94
SCU
sra
nd
om
ized
usi
ng
aco
into
ss
No
Exte
rnal
beh
avio
rale
nga
gem
ent:
soci
alb
ehav
iors
,act
ivit
ies,
tim
eu
se,a
nd
gazi
ng
wit
hin
tere
stas
mea
sure
dw
ith
the
wit
hd
raw
alfa
cto
ro
fth
eM
OSE
S156
asw
ella
sa
beh
avio
rra
tin
gsc
ale
and
anac
tivi
typ
arti
cip
atio
nsc
ale
dev
elo
ped
by
the
auth
ors
.Ob
serv
atio
ns
wer
era
ted
usi
ng
the
Ob
serv
edEm
oti
on
Rat
ing
Scal
e157
(pre
vio
usl
ykn
ow
nas
the
Ph
ilad
elp
hia
Ger
iatr
icC
ente
rA
ffec
tR
atin
gSc
ale.
158)
Sign
ifica
nt
incr
ease
for
acti
vite
san
dti
me
use
inex
per
imen
tal
gro
up
(mu
ltiv
aria
teF
=2.
51,
df=
14,2
72,p
<0.
01)
bu
tn
ot
con
tro
lgro
up
.No
sign
ifica
nt
chan
ges
for
pas
sive
beh
avio
rso
rga
zin
gw
ith
inte
rest
;no
sign
ifica
nt
effe
ctfo
rgr
ou
p×
tim
ein
tera
ctio
no
nin
tere
st.
10
Th
erap
euti
cac
tivi
ties
Ch
apm
anet
al.,
2004
,Un
ited
Stat
es13
2
Co
gnit
ive-
com
mu
nic
atio
nst
imu
lati
on
pro
gram
wit
hh
om
eas
sign
men
tsp
lus
do
nep
ezil
vers
us
do
nep
ezil
on
lyo
ver
8w
eeks
RC
T.8
and
12m
on
ths
f/u
50IT
Tan
d41
IAco
mm
un
ity-
dw
ellin
go
lder
adu
lts
wit
hm
ildto
mo
der
ate
AD
(29
fem
ales
);in
terv
enti
on
gro
up
N=
26,
con
tro
lgro
up
N=
28
Ran
do
mas
sign
men
tge
ner
ated
usi
ng
SAS
stat
isti
cal
soft
war
e(S
AS
Inst
itu
te,C
ary,
NC
).
Ap
ath
yit
emra
ters
blin
ded
Ap
ath
ych
ange
sco
res
asm
easu
red
by
the
NP
I.55
Ap
ath
ych
ange
sco
res
for
the
cogn
itiv
e-co
mm
un
icat
ion
pro
gram
wit
hd
on
epez
ilap
pro
ach
edsi
gnifi
can
ce(M
=−1
.10,
p=
0.08
)su
gges
tin
gre
du
ced
apat
hy
ove
rti
me.
Low
erap
ath
ysc
ore
sm
ain
tain
edat
follo
w-u
p.
12
(Con
tin
ued
)
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
554 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and BurnsT
AB
LE1.
(Co
nti
nu
ed)
Stu
dy
Inte
rven
tio
ns
Stu
dy
Des
ign
Fo
llo
w-u
pN
um
ber
Met
ho
do
fR
and
om
izat
ion
Bli
nd
ing
of
Rat
ers
Ou
tco
mes
Rel
evan
tto
Ap
ath
ySi
gnifi
can
ceQ
ual
ity
Rat
ing
Git
linet
al.,
2008
,U
nit
edSt
ates
134
Tai
lore
dA
ctiv
ity
Pro
gram
,an
OT
inte
rven
tio
no
fac
tivi
ties
cust
om
ized
toca
pab
iliti
esd
uri
ng
6×
90m
inu
tes
ho
me
visi
tsan
d2
×15
min
ute
sp
ho
ne
con
tact
so
ver
4m
on
ths
vers
us
wai
t-lis
tco
ntr
ol/
del
ayed
inte
rven
tio
ngr
ou
p
Cro
sso
ver
RC
T.
No
f/u
60IT
Tan
d56
IAp
atie
nts
wit
hd
emen
tia
livin
gin
the
com
mu
nit
yan
dth
eir
care
give
rs(2
6fe
mal
es);
inte
rven
tio
ngr
ou
pN
=30
,co
ntr
olg
rou
pN
=30
Ran
do
miz
edu
sin
gra
nd
om
per
mu
ted
blo
cks.
Par
tici
pan
tsal
sose
rved
asth
eir
ow
nco
ntr
ols
Yes
Act
ivit
yen
gage
men
tm
easu
red
wit
ha
five
-item
,in
vest
igat
or-
dev
elo
ped
ind
exo
fca
regi
ver
rep
ort
.
Sign
ifica
nt
incr
ease
inac
tivi
tyen
gage
men
t(F
[1,1
08]=
5.1,
p=
0.03
,C
oh
en’s
d=
0.61
)an
dab
ility
toke
epb
usy
(F[1
,108
]=
6.2,
p=
0.02
Co
hen
’sd
=0.
71)
intr
eatm
ent
gro
up
bu
tn
ot
con
tro
lgro
up
12
Ko
lan
ow
ski,
2005
,U
nit
edSt
ates
159
Act
ivit
ies
mat
ched
tosk
illle
velo
nly
vers
us
acti
viti
esm
atch
edto
styl
eo
fin
tere
sto
nly
vers
us
acti
viti
esm
atch
edto
bo
thsk
illle
vela
nd
styl
eo
fin
tere
stim
ple
men
ted
for
up
to20
min
ute
sd
aily
ove
r12
con
secu
tive
day
s
Inte
rru
pte
dti
me
seri
esw
ith
ou
tp
aral
lelc
on
tro
lgr
ou
p.N
of/
u
33IT
Tan
d30
IAN
Hre
sid
ents
wit
hd
emen
tia
(23
fem
ales
)
Ord
ero
fco
nd
itio
nra
nd
om
ized
wit
hp
erm
ute
db
lock
edra
nd
om
izat
ion
sch
eme.
Par
tici
pan
tsse
rved
asth
eir
ow
nco
ntr
ols
Enga
gem
ent
rate
rsb
lind
ed
Pas
sivi
tyas
mea
sure
db
yth
e12
pas
sive
beh
avio
rit
ems
of
the
Pas
sivi
tyin
Dem
enti
aSc
ale16
0as
wel
las
enga
gem
ent
asm
easu
red
by
tim
eo
nta
skan
din
ten
sity
of
par
tici
pat
ion
.
Sign
ifica
nt
imp
rove
men
tin
pas
sivi
tyan
den
gage
men
t(p
≤0.
001)
wh
enac
tivi
ties
wer
em
atch
edto
styl
eo
fin
tere
sto
rm
atch
edto
bo
thsk
illle
vela
nd
styl
eo
fin
tere
st.
12
Po
litis
etal
.,20
04,
Un
ited
Stat
es16
1
Kit
-bas
edac
tivi
tyin
terv
enti
on
vers
us
on
eto
on
eti
me
and
atte
nti
on
inte
rven
tio
nfo
r30
min
ute
s,3
×p
erw
eek
ove
r4
wee
ks
RC
T.N
of/
u36
resi
den
tso
fa
spec
ialis
tlo
ng-
term
dem
enti
aca
refa
cilit
y(1
8fe
mal
es);
inte
rven
tio
ngr
ou
pN
=18
,co
ntr
olg
rou
pN
=18
Tab
leo
fra
nd
om
nu
mb
ers
inb
lock
so
f4
Rat
ers
mas
ked
totr
eatm
ent
assi
gnm
ent
Ap
ath
yd
om
ain
of
the
NP
I55an
dac
tivi
typ
arti
cip
atio
nas
mea
sure
db
yth
eC
RA
Ias
dev
elo
ped
by
Co
pp
erR
idge
Inst
itu
te.16
1
Sign
ifica
nt
wit
hin
gro
up
imp
rove
men
tso
nN
PI
apat
hy
inb
oth
kit-
bas
edin
terv
enti
on
gro
up
(z=
−1.
92,p
=0.
05)
and
on
eto
on
ein
terv
enti
on
gro
up
(z=
−2.
68,p
=0.
01).
No
sign
ifica
nt
dif
fere
nce
bet
wee
ngr
ou
ps
inac
tivi
typ
arti
cip
atio
no
nth
eC
RA
I
12
Mis
cella
neo
us
Cam
ber
get
al.,
1999
,U
nit
edSt
ates
162
Sim
Pre
s,i.e
.,p
erso
nal
ized
aud
iota
pes
wh
ich
aim
tore
plic
ate
the
pre
sen
ceo
fca
regi
ver
vers
us
pla
ceb
oau
dio
tap
eo
fem
oti
on
ally
neu
tral
new
spap
erar
ticl
esve
rsu
su
sual
care
for
17d
ays
ove
r4
wee
ksw
ith
a10
-day
was
ho
ut
per
iod
bet
wee
ntr
eatm
ents
Pse
ud
o-R
CT
.No
f/u
54re
sid
ents
wit
hd
emen
tia
fro
m9
NH
s(4
8fe
mal
es)
Inte
rven
tio
nap
plie
din
are
stri
ctiv
ely
ran
do
miz
edm
ann
erw
hen
staf
fch
ose
eith
erin
terv
enti
on
or
pla
ceb
ota
pe
tom
anag
ere
sid
ent
beh
avio
rs
NH
staf
fan
dtr
ain
edn
on
par
tici
-p
ant
ob
serv
ers
blin
ded
toau
dio
tap
eco
nte
nt
Wit
hd
raw
nb
ehav
ior
defi
ned
asla
cko
fin
tere
stin
peo
ple
,ac
tivi
ties
,or
thin
gsin
par
tici
pan
ts’e
nvi
ron
men
tco
mb
ined
wit
hsa
dm
oo
das
mea
sure
db
yth
ein
tere
stan
dp
leas
ure
item
so
fth
eO
bse
rved
Emo
tio
nR
atin
gSc
ale15
7
(pre
vio
usl
ykn
ow
nas
the
Ph
ilad
elp
hia
Ger
iatr
icC
ente
rA
ffec
tR
atin
gSc
ale15
8)
and
aw
ith
dra
wn
visu
alan
alo
gue
scal
ew
ith
anch
ors
of
“ap
ath
y”an
d“e
nga
gem
ent.
”
Staf
fo
bse
rvat
ion
logs
ind
icat
edth
atSi
mP
res
imp
rove
dw
ith
dra
wn
beh
avio
ro
nsi
gnifi
can
tly
mo
reo
ccas
ion
s(6
9%)
than
usu
alca
re(5
5%;
p<
0.00
)an
dp
lace
bo
(34%
;p<
0.00
);d
irec
to
bse
rvat
ion
ssh
ow
edn
osi
gnifi
can
td
iffe
ren
ces
bet
wee
nco
nd
itio
ns;
wee
kly
staf
fsu
rvey
sin
dic
ated
that
12
(Con
tin
ued
)
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 555
Nonpharmacological Management of Apathy in Dementia
TA
BLE
1.
(Co
nti
nu
ed)
Stu
dy
Inte
rven
tio
ns
Stu
dy
Des
ign
Fo
llo
w-u
pN
um
ber
Met
ho
do
fR
and
om
-iz
atio
nB
lin
din
go
fR
ater
sO
utc
om
esR
elev
ant
toA
pat
hy
Sign
ifica
nce
Qu
alit
yR
atin
g
Dat
aco
llect
ion
met
ho
ds
incl
ud
ed
aily
staf
fo
bse
rvat
ion
logs
(to
tal
ob
serv
atio
ns=
1981
)d
irec
to
bse
rvat
ion
san
dw
eekl
yst
aff
beh
avio
ralr
atin
gsu
rvey
s
Sim
Pre
sin
crea
sed
leve
lof
inte
rest
sign
ifica
ntl
ym
ore
than
pla
ceb
o(p
=0.
01)
and
usu
alca
re(p
=0.
00)
Laie
tal
.,20
04,H
on
gK
on
g,C
hin
a163
Ind
ivid
ual
rem
inis
cen
cep
rogr
amw
eekl
yfo
r30
min
ute
so
ver
6w
eeks
vers
us
soci
alco
nta
ctco
mp
aris
on
pro
gram
vers
us
no
inte
rven
tio
n
RC
T.6
wee
kf/
u10
1IT
Tan
d86
IAN
Hre
sid
ents
wit
hd
emen
tia
(69
fem
ales
);in
terv
enti
on
gro
up
N=
36,c
on
tro
lgr
ou
pN
=30
,co
mp
aris
on
gro
up
N=
35
Fix
ed allo
cati
on
ran
do
miz
a-ti
on
164
Ass
esso
rsb
lind
edto
par
tici
-p
ant
assi
gn-
men
t
Enga
gem
ent,
e.g.
,in
tera
ctio
n,
self
-init
iate
dac
tivi
ties
,an
din
volv
emen
tas
mea
sure
dw
ith
the
Soci
alEn
gage
men
tSc
ale16
5,1
66
Sign
ifica
nt
dif
fere
nce
ove
rti
me
wit
hin
inte
rven
tio
ngr
ou
p(p
=0.
014)
bu
tn
ot
the
com
par
iso
no
rco
ntr
olg
rou
ps.
No
sign
ifica
nt
dif
fere
nce
bet
wee
nsu
bje
ctef
fect
so
rw
ith
insu
bje
ctef
fect
sfo
rin
tera
ctio
nb
etw
een
tim
ean
dgr
ou
po
rb
etw
een
tim
ean
dre
gula
rp
rogr
am
13
Sch
rijn
e-m
aeke
rset
al.,
2002
,N
eth
erla
nd
s167
Emo
tio
n-o
rien
ted
care
,168
bas
edo
nva
lidat
ion
,169
rem
inis
cen
ce,
and
sen
sory
stim
ula
tio
nap
pro
ach
esve
rsu
su
sual
care
ove
r12
mo
nth
s
Clu
ster
edp
seu
do
-RC
T.
No
f/u
151
resi
den
tsw
ith
cogn
itiv
eim
pai
rmen
tan
db
ehav
iora
lpro
ble
ms
atte
nd
ing
stru
ctu
red
day
-car
eu
nit
sin
16N
Hs
(136
fem
ales
);in
terv
enti
on
gro
up
N=
77,c
on
tro
lgr
ou
pN
=74
NH
sra
nd
om
-iz
ed.
Met
ho
dn
ot
stat
ed
No
Ap
ath
etic
and
no
nso
cial
beh
avio
rsu
bsc
ales
of
the
sho
rtve
rsio
no
fth
eG
IP15
3at
bas
elin
e,3
mo
nth
s,6
mo
nth
s,an
d12
mo
nth
s
No
sign
ifica
nt
dif
fere
nce
bet
wee
nin
terv
enti
on
and
con
tro
lgro
up
sfo
rap
ath
etic
or
no
nso
cial
beh
avio
rs.
11
Tad
aka
and
Kan
agaw
a,20
07,
Jap
an13
7
RT
du
rin
g60
–90
min
ute
sw
eekl
yse
ssio
ns
vers
us
rou
tin
ed
ayca
rese
rvic
eo
ver
8co
nse
cuti
vew
eeks
RC
T.6
mo
nth
f/u
60IT
Tan
d50
IAel
der
lyat
ten
dee
so
fco
mm
un
ity
day
care
wit
hd
emen
tia
(20
AD
,30
VaD
,42
fem
ales
);in
terv
enti
on
gro
up
N=
30,c
on
tro
lgr
ou
pN
=30
Co
mp
ute
r-ge
ner
ated
ran
do
miz
a-ti
on
wit
hin
sub
sets
of
dem
enti
aty
pe
No
Deg
ree
of
wit
hd
raw
alas
mea
sure
db
yth
ew
ith
dra
wal
sub
scal
eo
fth
eM
OSE
S156
Sign
ifica
nt
imp
rove
men
to
nw
ith
dra
wal
for
RT
inA
Dgr
ou
pim
med
iate
lyfo
llow
ing
inte
rven
tio
nb
ut
no
tat
follo
w-u
p(p
<0.
05);
sign
ifica
nt
imp
rove
men
tim
med
iate
lyfo
llow
ing
inte
rven
tio
nan
dat
follo
wu
po
nw
ith
dra
wal
for
RT
inV
aDgr
ou
p(p
<0.
01)
11
Not
es:N
H:n
ursi
ngho
me;
MSS
:mul
tise
nsor
yst
imul
atio
n;B
RS:
Beh
avio
ralR
atin
gSc
ale;
CR
AI:
Cop
per
Rid
geA
ctiv
itie
sIn
dex
;f/
u:fo
llow
up;G
IP:G
edra
gsob
serv
atie
scha
alvo
ord
eIn
tram
ural
ePs
ycho
geri
atri
e[D
utch
Beh
avio
rR
atin
gSc
ale
for
Psyc
hoge
riat
ric
Inpa
tien
ts];
IA:i
nan
alys
is;I
TT:
inte
ntio
nto
trea
t;M
OSE
S:M
ulti
dim
ensi
onal
Obs
erva
tion
Scal
efo
rE
lder
lySu
bjec
ts;N
PI:n
euro
psyc
hiat
ric
inve
ntor
y;O
T:oc
cupa
tion
alth
erap
y;R
T:re
min
isce
nce
ther
apy;
Sim
Pres
:Sim
ulat
edPr
esen
ceT
hera
py;S
CU
:spe
cial
care
unit
;VaD
:vas
cula
rd
emen
tia.
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
556 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and Burns
TABLE 2. Summary of NHMRC Levels of Evidence for Included Studies
Positive Outcome Nonsignificant OutcomeNHMRC levels ofevidencea126 II III IV II III IV
Intervention groupExercise 0 1 0 1 1 0Music 0 8 1 0 0 1Multisensory stimulation 0 5 0 1 0Animals 0 4 3 0 0 0Special care
programming1 1 2 0 1 0
Therapeutic activities 1 12 0 2 0 0Miscellaneous 1 6 0 0 3 0
Notes: aNo level I systematic reviews included.
lack of controlled studies. Special care programmingincludes five studies of which one met criteria forlevel II, one met criteria for level III-2, and threeranked at III-3 or less. Four of the five studies havepositive results. Therapeutic activity studies ratebetter overall with three RCTs at level II and sevenstudies at III-1. All but two report positive outcomes.Miscellaneous interventions, including two RCTsranked at level II and five pseudorandomized con-trolled trials at level III-1, are a heterogenous groupmaking it difficult to draw conclusions.
DISCUSSION
Apathy while common in dementia58 is often ig-nored even though it contributes to lower quality oflife in people with dementia170,171 and causes signifi-cant distress to caregivers.101,150,172 Interventions arewarranted,1,100,173–176 but there is a paucity of soundresearch to guide clinicians and caregivers. Manynonpharmacological interventions are the subject ofa limited number of studies,177 and others such asremotivation therapy,178 structured daily routine, arttherapy, psychomotor therapy, humor therapy,179 andvalidation therapy169 are not represented here or havebeen excluded.
From the literature reviewed, the only interventionwith sufficient quality studies, here defined as 11 ormore on our research quality scale, was Therapeu-tic Activities. Some benefit for apathy in dementiais apparent, although this is a heterogeneous group,which includes stimulation, creative activities, cook-ing, Montessori methods, and behavioral elements,often individually tailored. Some positive results,
although even less impressive, were reported for mu-sic, exercise, multisensory stimulation, pet therapy,and special care units. However, the evidence for ef-ficacy of these interventions is far from convincing,as the standard of research was generally low, withonly 12 out of 57 studies reaching an arbitrary stan-dard of 11 out of 15 on a rating scale of quality. Fur-thermore, there is scant evidence of sustainability ofeffect once intervention ceases. Studies that reportedmaintenance of benefits in the community reflect con-tinued activities by family caregivers.
A lack of quality research is not necessarily in-dicative of a lack of efficacy.174 Studies may reportanecdotal, qualitative evidence, which can be difficultto capture quantitatively and high-quality researchparticularly in large numbers is labor-intensive andexpensive. Likewise, reliance on randomized studiesexcludes possibilities arising from the natural setting.While this creates potential threats to validity, suchsituations are impractical to randomize. Validityis a key criterion when assessing research quality,but applicability and clinical relevance are alsoimportant.180 Although significant differences maynot be demonstrated with a repeated-measures de-sign, this may nonetheless be an appropriate choicedue to the predicted trajectory of increasing apathywith dementia severity.39,181,182 Stabilization of par-ticipants’ apathy, in the face of disease progression,may indicate that the intervention is beneficial evenwithout evidence of improvement.
Quality research is necessary to determine conse-quences of providing or delaying pharmacologicalinterventions.183 Although general treatment prin-ciples for behavioral and psychological symptomsof dementia (BPSD) recommend commencing with
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 557
Nonpharmacological Management of Apathy in Dementia
psychosocial interventions,184 initial treatment forBPSD is often pharmacological possibly becauseof the lack of evidence for nonpharmacologicalapproaches.183 As effect sizes were largely inaccessi-ble, comparison of nonpharmacological versus phar-macological interventions alone or in combinationwas not viable. Only one study in this review evalu-ated a psychosocial intervention in combination withdrug treatment.132 Scientific and financial invest-ment into the pharmacological treatment of cognitiveimpairment in dementia plainly outweighs invest-ment into management of behavioral symptoms,185
although neuropsychiatric features may be as signifi-cant as cognitive losses.186
LIMITATIONS
The potential confounds of studying apathy in de-mentia are numerous: a lack of standardized, assess-ment guidelines for diagnosing apathy; difficultiesin differentiating it from and overlap with depres-sion, fatigue syndromes, and parkinsonism;187–190 un-derreporting of apathy;72 and similar symptoms sec-ondary to medications such as psychotropics andbeta-blockers.29 Furthermore, severity of dementialikely influences the success of interventions trialed,yet many studies treated participants as a homoge-nous group. The degree to which findings can begeneralized across the stages of dementia is largelyunknown.191 While 12 studies specified a level of de-mentia, small participant numbers preclude separat-ing these according to disease severity.
The multiple components of psychosocial interven-tions often overlap making it difficult to determinewhich aspect is the active ingredient.184 Where stud-ies report similar interventions, differing care envi-ronments and procedures lead to difficulty in de-termining consistency of delivery. Likewise, manydisparate instruments and tools have been usedto collect behavioral data, with only some beingwell-validated. Consistency in gathering and report-ing outcomes would facilitate useful comparisonsbetween studies and aid in developing effectivemanagement strategies. Distal outcomes of apatheticbehaviors such as time to residential care placement,effects on caregivers, and complications of immobil-ity are also neglected.
Research is hampered by the difficulties of recruit-ing and retaining numbers to ensure sufficient power.Ethical issues also arise when recruiting and ob-taining consent from apathetic participants. Further-more, maintaining compliance with interventionsand study design in the “real world” often requiresmuch supervision, support, and encouragement onthe caregiver’s part. When individual improvementsare not evident, caregivers’ motivation and commit-ment may diminish. Both, family and paid caregiversare classically overloaded in their roles thereby in-creasing the risk of withdrawal from studies.
The impoverished physical and social environmentof institutional care can further inhibit motivation,as can sensory impairments.9 Within residential fa-cilities, avoiding contamination across groups posesan additional challenge. The mere presence of re-searchers or any intervention, beyond the daily rou-tine, can incite stimulation and interest among theresidents, their families, and staff, making it impossi-ble to provide true control conditions for comparison.Usual care or programming varies markedly betweenresearch contexts and hence differences between con-trol and intervention conditions are inconsistent. Fi-nally, funding is difficult to obtain for nonpharma-cological research. Limited synthesis of studies wasperformed, but meta-analysis was not possible due tovariations in the delivery of interventions, outcomemeasurement, and reporting as well as methodology.
FUTURE RESEARCH
Apathy is as a major source of caregiver distressand frustration for those living at home.192 As a neg-ative symptom, however, apathy tends to pose lessovert disruption and economic consequences in resi-dential care settings relative to the more agitated andaggressive BPSD.193,194 Improved quality of life andcare, through reduced apathy, is more difficult to rec-ognize and quantify. Targeting apathy may alert care-givers at home or in residential care settings to an ad-ditional problem that would not normally demandtheir attention. The secondary benefits of successfulinterventions may be better evident in social gains ormaintenance of functional abilities as well as staff re-tention, job satisfaction, and/or increased family in-put in residential care.
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
558 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and Burns
Research has proposed matching activities to indi-vidual interests and retained skills to engage personswith dementia and maintain involvement.195–197
A biopsychosocial approach to managing apathyrecognizes that there are multiple contributorsto apathetic behaviors. Acknowledging individ-uality, personal history, and previous interestsmay forecast individual strategies for engagingthose with apathetic behaviors101,178,198 as well asvariations in response.199 Person-centered care200
likewise seeks to view the person as a whole, in-corporating the individual’s personal and socialpsychology. While a “one size fits all” approachto managing apathy in dementia may be inappro-priate, individualized programs require additionalresources. The benefits to care providers and orga-nizations must ultimately outweigh implementationcosts.
The implications of this review are that non-pharmacological interventions have the potentialto reduce apathy in dementia. Apathy is complexand multifaceted and further rigorous research isneeded201–203 including the investigation of integra-tive approaches possibly in combination with phar-macological interventions.94 Future research shouldconsider confounds such as depression, medicationeffects, metabolic disorders, environmental differ-ences, and concurrent acute and/or chronic illnesses.Randomized, blinded, controlled studies with apathyas a primary outcome and longer-term follow-up us-ing validated, reliable outcome measures of apathywould advance the evaluation of nonpharmacolog-ical management. In the meantime, the use of ther-apeutic activities has the best available evidence foreffectiveness, particularly when these are providedindividually.
References
1. Landes AM, Sperry SD, Strauss ME, et al: Apathy in Alzheimer’sdisease. J Am Geriatr Soc 2001; 49:1700–1707
2. Pluck GC, Brown RG: Apathy in Parkinson’s disease. J NeurolNeurosurg Psychiatry 2002; 73:636–642
3. Brown RG, Pluck G: Negative symptoms: the ‘pathology’ ofmotivation and goal-directed behaviour. Trends Neurosci 2000;23:412–417
4. Burns A, Folstein S, Brandt J, et al: Clinical assessment of irritabil-ity, aggression, and apathy in Huntington and Alzheimer disease.J Nerv Ment Dis 1990; 178:20–26
5. Levy ML, Cummings JL, Fairbanks LA, et al: Apathy is not depres-sion. J Neuropsychiatry Clin Neurosci 1998; 10:314–319
6. Overshott R, Byrne J, Burns A: Nonpharmacological and phar-macological interventions for symptoms in Alzheimer’s disease.Expert Rev Neurotherap 2004; 4:809–821
7. Tagariello P, Girardi P, Amore M: Depression and apathy in de-mentia: same syndrome or different constructs? A critical review.Arch Gerontol Geriat 2009; 49:246–249
8. Vijayaraghavan L, Krishnamoorthy ES, Brown RG, et al: Abulia:a Delphi survey of British neurologists and psychiatrists. MovDisord 2002; 17:1052–1057
9. Duffy JD: Apathy in neurologic disorders. Current PsychiatryReports 2000; 2:434–439
10. Marin RS, Fogel BS, Hawkins J, et al: Apathy: a treatable syn-drome. J Neuropsychiatry Clin Neurosci 1995; 7:23–30
11. McAllister TW: Apathy. Semin Clin Neuropsychiatry 2000;5:275–282
12. Marin RS: Apathy: a neuropsychiatric syndrome. J Neuropsychi-atry Clin Neurosci 1991; 3:243–254
13. Robert PH, Darcourt G, Koulibaly MP, et al: Lack of initiativeand interest in Alzheimer’s disease: a single photon emissioncomputed tomography study. Eur J Neurol 2006; 13:729–735
14. Stuss DT, van Reekum R, Murphy KJ: Differentiation of statesand causes of apathy, in The Neuropsychology of Emotion.Edited byBorod JC. New York, Oxford University Press, 2000,340–363
15. Marin RS: Differential diagnosis and classification of apathy. AmJ Psychiatry 1990; 147:22–30
16. Starkstein SE: Apathy and withdrawal. Int Psychogeriatr. 2000;12: 135–137
17. Starkstein SE, Leentjens AF: The nosological position of apathy inclinical practice. J Neurol Neurosurg Psychiatry 2008; 79:1088–1092
18. Robert P, Onyike CU, Leentjens AFG, et al: Proposed diagnosticcriteria for apathy in Alzheimer’s disease and other neuropsychi-atric disorders. Eur Psychiatry. 2009; 24:98–104
19. Robert PH, Mulin E, Mallea P, et al: Apathy diagnosis, assessment,and treatment in Alzheimer’s disease. CNS Neurosci Ther 2010;16:263–271
20. Wongpakaran N, Van Reekum R, Wongpakaran T, et al: Se-lective serotonin reuptake inhibitor use associates with apathyamong depressed elderly: a case-control study. Ann Gen Psychi-atry 2007; 6:7
21. Barnhart WJ, Makela EH, Latocha MJ: SSRI-induced apathysyndrome: a clinical review. J Psychiatr Pract 2004; 10:196–199
22. Brodaty H, Sachdev PS, Withall A, et al: Frequency and clini-cal, neuropsychological and neuroimaging correlates of apathyfollowing stroke: the Sydney Stroke Study. Psychol Med 2005;35:1707–1716
23. Marin RS, Firinciogullari S, Biedrzycki RC: The sources of con-vergence between measures of apathy and depression. J AffectDisord 1993; 28:7–14
24. Marin RS, Firinciogullari S, Biedrzycki RC: Group differences inthe relationship between apathy and depression. J Nerv MentDis 1994; 182:235–239
25. Starkstein SE, Jorge R, Mizrahi R, et al: A prospective longitudi-nal study of apathy in Alzheimer’s disease. J Neurol NeurosurgPsychiatry 2006; 77:8–11
26. McPherson S, Fairbanks L, Tiken S, et al: Apathy and executivefunction in Alzheimer’s disease. J Int Neuropsychol Soc 2002;8:373–381
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 559
Nonpharmacological Management of Apathy in Dementia
27. Webster J, Grossberg GT: Disinhibition, apathy, indifference,fatigability, complaining, and negativism. Int Psychogeriatr 1996;8:403–408
28. Reichman WE, Coyne AC, Amirneni S, et al: Negative symptomsin Alzheimer’s disease. Am J Psychiatry. 1996; 153:424–426
29. Colling KB: Passive behaviors in dementia. Clinical applicationof the need-driven dementia-compromised behavior model. JGerontol Nurs 1999; 25:27–32
30. Marin RS: Apathy: concept, syndrome, neural mechanisms, andtreatment. Semin Clin Neuropsychiatry 1996; 1:304–314
31. Ghosh BCP, Rowe JB, Calder AJ, et al: Emotion recognition inprogressive supranuclear palsy. J Neurol Neurosurg Psychiatry1998; 80:1143–1145
32. Litvan I, Mega M, Cummings J, et al: Neuropsychiatric aspects ofprogressive supranuclear palsy. Neurology 1996; 47:1184–1189
33. Litvan I, Paulsen JS, Mega MS, et al: Neuropsychiatric assessmentof patients with hyperkinetic and hypokinetic movement disor-ders. Arch Neurol 1998; 55:1313–1319
34. Litvan I, Cummings JL, Mega M: Neuropsychiatric features ofcorticobasal degeneration. J Neurol Neurosur Psychiatry 1998;65:717–721
35. Shinagawa S, Ikeda M, Fukuhara R, et al: Initial symptoms infrontotemporal dementia and semantic dementia compared withAlzheimer’s disease. Dement Geriatr Cogn Disord 2006; 21:74–80
36. Hodges JR: Frontotemporal dementia (Pick’s disease): clinicalfeatures and assessment. Neurology 2001; 56:S6–S10
37. Levy ML, Miller BL, Cummings JL, et al: Alzheimer disease andfrontotemporal dementias. Behavioral distinctions. Arch Neurol1996; 53:687–690
38. Liu W, Miller BL, Kramer JH, et al: Behavioral disorders in thefrontal and temporal variants of frontotemporal dementia. Neu-rology. 2004; 62:742–748
39. Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behav-ioral changes in Alzheimer’s disease. Neurology 1996; 46:130–135
40. Craig D, Mirakhur A, Hart DJ, et al: A cross-sectional study ofneuropsychiatric symptoms in 435 patients with Alzheimer’s dis-ease. Am J Geriatr Psychiatry 2005; 13:460–468
41. Piccininni M, Di Carlo A, Baldereschi M, et al: Behavioral andpsychological symptoms in Alzheimer’s disease: frequency andrelationship with duration and severity of the disease. DementGeriatr Cogn Disord 2005; 19:276–281
42. Lyketsos CG, Lopez O, Jones B, et al: Prevalence of neu-ropsychiatric symptoms in dementia and mild cognitive impair-ment: results from the cardiovascular health study. JAMA 2002;288:1475–1483
43. Aalten P, de Vugt ME, Jaspers N, et al: The course of neuropsy-chiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry 2005;20:523–530
44. Robert PH, Verhey FRJ, Byrne EJ, et al: Grouping for behavioraland psychological symptoms in dementia: clinical and biologicalaspects. Consensus paper of the European Alzheimer diseaseconsortium. Eur Psychiatry: J Assoc Eur Psychiatr 2005; 20:490–496
45. Benoit M, Clairet S, Koulibaly PM, et al: Brain perfusion correlatesof the apathy inventory dimensions of Alzheimer’s disease. Int JGeriatr Psychiatry 2004; 19:864–869
46. Craig AH, Cummings JL, Fairbanks L, et al: Cerebral blood flowcorrelates of apathy in Alzheimer disease. Arch Neurol 1996;53:1116–1120
47. Benoit M, Koulibaly PM, Migneco O, et al: Brain perfusion inAlzheimer’s disease with and without apathy: a SPECT study withstatistical parametric mapping analysis. Psychiatry Res 2002;114:103–111
48. Rosen HJ, Allison SC, Schauer GF, et al: Neuroanatomicalcorrelates of behavioural disorders in dementia. Brain 2005;128:2612–2625
49. Lam LCW, Tam CWC, Chiu HFK, et al: Depression and apathy af-fect functioning in community active subjects with questionabledementia and mild Alzheimer’s disease. Int J Geriatr Psychiatry2007; 22:431–437
50. Zawacki TM, Grace J, Paul R, et al: Behavioral problems as pre-dictors of functional abilities of vascular dementia patients. JNeuropsychiatry Clin Neurosci 2002; 14:296–302
51. Migneco O, Benoit M, Koulibaly PM, et al: Perfusion brain SPECTand statistical parametric mapping analysis indicate that apathyis a cingulate syndrome: a study in Alzheimer’s disease and non-demented patients. Neuroimage 2001; 13:896–902
52. Aarsland D, Cummings JL, Larsen JP: Neuropsychiatric dif-ferences between Parkinson’s disease with dementia andAlzheimer’s disease. Int J Geriatr Psychiatry 2001; 16:184–191
53. Savva GM, Zaccai J, Matthews FE, et al: Prevalence, correlates andcourse of behavioural and psychological symptoms of dementiain the population. Br J Psychiatry. 2009; 194:212–219
54. Benoit M, Staccini P, Brocker P, et al: Behavioral and psycho-logical symptoms in Alzheimer’s disease: results from REAL. FRstudy. Rev Med Interne. 2003; 24:319s–324s
55. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric In-ventory: comprehensive assessment of psychopathology in de-mentia. Neurology 1994; 44:2308–2314
56. Benoit M, Dygai I, Migneco O, et al: Behavioral and psychologicalsymptoms in Alzheimer’s disease. Relation between apathy andregional cerebral perfusion. Dement Geriatr Cogn Disord 1999;10:511–517
57. Hart DJ, Craig D, Compton SA, et al: A retrospective study of thebehavioural and psychological symptoms of mid and late phaseAlzheimer’s disease. Int J Geriatr Psychiatry 2003; 18:1037–1042
58. Starkstein SE, Jorge R, Mizrahi R: The prevalence, clinical cor-relates and treatment of apathy in Alzheimer’s disease. Eur JPsychiatry 2006; 20:96–106
59. Bostrom F, Jonsson L, Minthon L, et al: Patients with demen-tia with lewy bodies have more impaired quality of life thanpatients with Alzheimer disease. Alzheimer Dis Assoc Disord.2007; 21:150–154
60. Galvin J, Duda J, Kaufer D, et al: Lewy body dementia: caregiverburden and unmet needs. Alzheimer Dis Assoc Disord 2010;24:177–181
61. Borroni B, Agosti C, Padovani A: Behavioral and psychologicalsymptoms in dementia with Lewy-bodies (DLB): frequency andrelationship with disease severity and motor impairment. ArchGerontol Geriatr 2008; 46:101–106
62. Caine ED, Shoulson I: Psychiatric syndromes in Huntington’sdisease. Am J Psychiatry. 1983; 140:728–733
63. Paulsen JS, Ready RE, Hamilton JM, et al: Neuropsychiatric as-pects of Huntington’s disease. J Neurol Neurosurg Psychiatry.2001; 71:310–314
64. Hamilton JM, Salmon DP, Corey-Bloom J, et al: Behavioural abnor-malities contribute to functional decline in Huntington’s disease.J Neurol Neurosurg Psychiatry 2003; 74:120–122
65. Rosenblatt A, Leroi I: Neuropsychiatry of Huntington’s diseaseand other basal ganglia disorders. Psychosomatics. 2000; 41:24–30
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
560 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and Burns
66. Baudic S, Maison P, Dolbeau G, et al: Cognitive impairment re-lated to apathy in early Huntington’s disease. Dementia and Geri-atric Cognitive Disorders. 2006; 21:316–321
67. Caplan LR: Binswanger’s disease-revisited. Neurology 1995;45:626–633
68. Bernard B, Wilson R, Gilley D, et al: The dementia of Bin-swanger’s disease and Alzheimer’s disease cognitive, affective,and behavioral aspects. Neuropsychiatry Neuropsychol BehavNeurol 1994; 7:30–35
69. Staekenborg SS, Su T, van Straaten EC, et al: Behavioural and psy-chological symptoms in vascular dementia; differences betweensmall- and large-vessel disease. J Neurol Neurosurg Psychiatry2010; 81:547–551
70. Thanvi BR, Munshi SK, Vijaykumar N, et al: Neuropsychiatricnon-motor aspects of Parkinson’s disease. Postgrad Med J 2003;79:561–565
71. Borek LL, Chou KL, Friedman JH: Management of the behav-ioral aspects of Parkinson’s disease. Expert Rev Neurother 2007;7:711–725
72. Ferreri F, Agbokou C, Gauthier S: Recognition and managementof neuropsychiatric complications in Parkinson’s disease. CanMed Assoc J 2006; 175:1545–1552
73. Richard IH: Depression and apathy in Parkinson’s disease. CurrNeurol Neurosci Rep. 2007; 7:295–301
74. Ready RE, Friedman J, Grace J, et al: Testosterone deficiency andapathy in Parkinson’s disease: a pilot study. J Neurol NeurosurgPsychiatry. 2004; 75:1323–1326
75. Elias JW, Treland JE: Executive function in Parkinson’s diseaseand subcortical disorders. Semin Clin Neuropsychiatry 1999;4:34–40
76. Kirsch-Darrow LM, Fernandez HFM, Marsiske MP, et al: Disso-ciating apathy and depression in Parkinson disease. Neurology2006; 67:33–38
77. Galynker I, Prikhojan A, Phillips E, et al: Negative symptoms instroke patients and length of hospital stay. J Nerv Ment Dis 1997;185:616–621
78. Paranthaman R, Baldwin RC: Treatment of psychiatric syndromesdue to cerebrovascular disease. Int Rev Psychiatry 2006; 18:453–470
79. Bourgeois JA, Hilty DM, Chang CH, et al: Poststroke neuropsy-chiatric illness: an integrated approach to diagnosis and manage-ment. Curr Treat Opt Neurol. 2004; 6:403–420
80. Robinson RG: Neuropsychiatric consequences of stroke. AnnuRev Med. 1997; 48:217–229
81. Treiber KA, Lyketsos CG, Corcoran C, et al: Vascular factorsand risk for neuropsychiatric symptoms in Alzheimer’s dis-ease: the Cache County Study. Int Psychogeriatr 2008; 20:538–553
82. Geda YE, Smith GE, Knopman DS, et al: De novo genesis ofneuropsychiatric symptoms in mild cognitive impairment (MCI).Int Psychogeriatr 2004; 16:51–60
83. Robert PH, Berr C, Volteau M, et al: Apathy in patients withmild cognitive impairment and the risk of developing dementiaof Alzheimer’s disease: a one-year follow-up study. Clin NeurolNeurosurg 2006; 108:733–736
84. Hwang TJ, Masterman DL, Ortiz F, et al: Mild cognitive impair-ment is associated with characteristic neuropsychiatric symp-toms. Alzheimer Dis Assoc Disord 2004; 18:17–21
85. Ready RE, Ott BR, Grace J, et al: Apathy and executive dysfunc-tion in mild cognitive impairment and Alzheimer disease. Am JGeriatr Psychiatry 2003; 11:222–228
86. Crocco EA, Loewenstein DA: Psychiatric aspects of mild cogni-tive impairment. Current Psychiatry Reports 2005; 7:32–36
87. Copeland MP, Daly E, Hines V, et al: Psychiatric symptomatologyand prodromal Alzheimer’s disease. Alzheimer Dis Assoc Disord2003; 17:1–8
88. Bartolini M, Coccia M, Luzzi S, et al: Motivational symptomsof depression mask preclinical Alzheimer’s disease in elderlysubjects. Dement Geriatr Cogn Disord 2005; 19:31–36
89. Robert PH, Berr C, Volteau M, et al: Neuropsychological perfor-mance in mild cognitive impairment with and without apathy.Dement Geriatr Cogn Disord 2006; 21:192–197
90. Starkstein SE, Petracca G, Chemerinski E, et al: Syndromic validityof apathy in Alzheimer’s disease. Am J Psychiatry 2001; 158:872–877
91. Starkstein SE, Ingram L, Garau ML, et al: On the overlap betweenapathy and depression in dementia. J Neurol Neurosurg Psychi-atry. 2005; 76:1070–1074
92. Aarsland D, Litvan I, Larsen JP: Neuropsychiatric symptoms ofpatients with progressive supranuclear palsy and Parkinson’sdisease. J Neuropsychiatry Clin Neurosci 2001; 13:42–49
93. Colling KB: Caregiver interventions for passive behaviors in de-mentia: links to the NDB model. Aging Ment Health 2004; 8:117–125
94. Campbell JJ, Duffy JD: Treatment strategies in amotivated pa-tients. Psychiatr Ann 1997; 27:44–49
95. Overshott R, Burns A: Treatment of dementia. Neurol Pract.2005; 76:v53–v59
96. Sacks AL: Effects of Snoezelen behavior therapy on increasingindependence in activities of daily living of elders with dementiaon a short term geriatric psychiatric unit. United States—NewJersey: Fairleigh Dickinson University, 2005
97. Yamashita K, Iijima K, Kobayashi S: Relationship among activitiesof daily living, apathy, and subjective well-being in elderly peopleliving alone in a rural town. Gerontology 1999; 45:279–282
98. Diesfeldt HFA, Van Houte LR, Moerkens RM: Duration of survivalin senile dementia. Acta Psychiatr Scand 1986; 73:366–371
99. Williams A: Motivation and Dementia. Top Geriatr Rehabil 2005;21:123–126
100. Burgio L: Interventions for the behavioral complications ofAlzheimer’s disease: behavioral approaches. Int Psychogeriatr.1996; 8:45–52
101. van Reekum R, Stuss DT, Ostrander L: Apathy: why care? J Neu-ropsychiatry Clin Neurosci 2005; 17:7–19
102. MacMahon S, Kermode S: A clinical trial of the effect of aro-matherapy on motivational behaviour in a dementia care settingusing a single subject design. Aust J Holist Nurs 1998; 5:47–49
103. Morton I, Bleathman C: The effectiveness of validation therapy indementia: a pilot study. Int J Geriatr Psychiatry. 1991; 6:327–330
104. Carpenter B, Ruckdeschel K, Ruckdeschel H, et al: R-E-M psy-chotherapy: a manualized approach for long-term care residentswith depression and dementia. Clin Gerontol 2003; 25:25–49
105. Spaull D, Leach C, Frampton I: An evaluation of the effects of sen-sory stimulation with people who have dementia. Behav CognPsychother 1998; 26:77–86
106. Wareing LA, Coleman PG, Baker R: Multisensory environmentsand older people with dementia. Br J Ther Rehabil 1998; 5:624–629
107. Clair AA, Bernstein B: A preliminary study of music therapy pro-gramming for severely regressed persons with Alzheimer’s-typedementia. J Appl Gerontol 1990; 9:299–311
108. Peak JS, Cheston RI: Using simulated presence therapy with peo-ple with dementia. Aging Ment Health 2002; 6:77–81
109. Sterritt PF, Pokorny ME: Art activities for patients withAlzheimer’s and related disorders. Geriatr Nur (Lond) 1994;15:155–159
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 561
Nonpharmacological Management of Apathy in Dementia
110. Baker R, Bell S, Baker E, et al: A randomized controlled trial ofthe effects of multi-sensory stimulation (MSS) for people withdementia. Br J Clin Psychol 2001; 40:81–96
111. Droes RM, Breebaart E, Ettema TP, et al: Effect of integratedfamily support versus day care only on behavior and mood ofpatients with dementia. Int Psychogeriatr 2000; 12:99–115
112. Kovach CR, Henschel H: Behavior and participation during ther-apeutic activities on special care units. Activ Adapt Aging 1996;20:35–45
113. Lund DA, Hill RD, Caserta MS, et al: Video Respite(TM): an inno-vative resource for family, professional caregivers, and personswith dementia. Gerontologist 1995; 35:683–687
114. van Weert JC, van Dulmen AM, Spreeuwenberg PM, et al: Effectsof snoezelen, integrated in 24 h dementia care, on nurse-patientcommunication during morning care. Patient Educ Couns 2005;58:312–326
115. Woods P, Ashley J: Simulated presence therapy: using selectedmemories to manage problem behaviors in Alzheimer’s diseasepatients. Geriatr Nur (Lond) 1995; 16:9–14
116. Paire JA, Karney RJ: The effectiveness of sensory stimulation forgeropsychiatric inpatients. Am J Occup Ther 1984; 38:505–509
117. Bernstein PL, Friedman E, Malaspina A: Animal-assisted therapyenhances resident social interaction and initiation in long-termcare facilities. Anthrozoos 2000; 13:213–224
118. Mills VM, Karas A, Alexander MP: Outpatient rehabilitation ofpatients with chronic cognitive impairments after ruptured an-terior communicating artery aneurysms reduces the burden ofcare: a pilot study. Brain Injury. 2006; 20:1183–1188
119. Palo-Bengtsson L, Winblad B, Ekman SL: Social dancing: a wayto support intellectual, emotional and motor functions in per-sons with dementia. J Psychiatr Ment Health Nurs 1998; 5:545–554
120. Scott J, Teasdale JD, Paykel ES, et al: Effects of cognitive therapyon psychological symptoms and social functioning in residualdepression. Br J Psychiatry 2000; 177:440–446
121. Tondi L, Ribani L, Bottazzi M, et al: Validation therapy (VT) innursing home: a case-control study. Arch Gerontol Geriatr 2007;44:407–411
122. Toseland RW, Diehl M, Freeman K, et al: The impact of validationgroup therapy on nursing home residents with dementia. J ApplGerontol 1997; 16:31–50
123. Hokkanen LP, Rantala LP, Remes AMMDP, et al: Dance/movement therapeutic methods in management of dementia.J Am Geriatr Soc 2003; 51:576–577
124. Walsh PG, Mertin PG, Verlander DF, et al: The effects of a ‘petsas therapy’ dog on persons with dementia in a psychiatric ward.Aust Occup Ther J 1995; 42:161–166
125. Maher CG, Sherrington C, Herbert RD, et al: Reliability of thePEDro scale for rating quality of randomized controlled trials.Phys Ther 2003; 83:713–721
126. National Health and Medical Research Council: Additional levelsof evidence and grades for recommendations for developers ofguidelines: final draft. Canberra: National Health and MedicalResearch Council, 2009
127. Verhagen AP, De Vet HCW, De Bie RA, et al: The Delphi list: acriteria list for quality assessment of randomized clinical trials forconducting systematic reviews developed by Delphi consensus.J Clin Epidemiol. 1998; 51:1235–1241
128. Vink AC, Birks JS, Bruinsma MS, et al: Music therapy for peoplewith dementia. Cochrane Database Syst Rev 2004; CD003477
129. Berman K, Brodaty H, Withall A, Seeher K: Pharmacologicaltreatment of apathy in dementia. Am J Geriatr Psychiatry 2012;20:104-122
130. National Health and Medical Research Council: How to reviewthe evidence: systematic identification and review of the scien-tific literature. Canberra: National Health and Medical ResearchCouncil, 1999
131. National Health and Medical Research Council: How to use theevidence: assessment and application of scientific evidence. Can-berra: National Health and Medical Research Council, 2000
132. Chapman SB, Weiner MF, Rackley A, et al: Effects of cognitive-communication stimulation for Alzheimer’s disease patientstreated with donepezil. J Speech Lang Hear Res 2004; 47:1149–1163
133. Fitzsimmons S, Buettner LL: Therapeutic recreation inter-ventions for need-driven dementia-compromised behaviors incommunity-dwelling elders. Am J Alzheimers Dis Other Demen2002; 17:367–381
134. Gitlin LN, Winter L, Burke J, et al: Tailored activities to man-age neuropsychiatric behaviors in persons with dementia andreduce caregiver burden: a randomized pilot study. Am J GeriatrPsychiatry 2008; 16:229–239
135. Weber K, Meiler-Mititelu C, Herrmann FR, et al: Longitudinalassessment of psychotherapeutic day hospital treatment for neu-ropsychiatric symptoms in dementia. Aging Ment Health 2009;13:92–98
136. Droes RM, Meiland F, Schmitz M, et al: Effect of combined sup-port for people with dementia and carers versus regular day careon behaviour and mood of persons with dementia: results from amulti-centre implementation study. Int J Geriatr Psychiatry 2004;19:673–684
137. Tadaka E, Kanagawa K: Effects of reminiscence group in elderlypeople with Alzheimer disease and vascular dementia in a com-munity setting. Geriatr Gerontol Int 2007; 7:167–173
138. Sherratt K, Thornton A, Hatton C: Emotional and behaviouralresponses to music in people with dementia: an observationalstudy. Aging Ment Health. 2004; 8:233–241
139. Baker R, Holloway J, Holtkamp CC, et al: Effects of multi-sensorystimulation for people with dementia. J Adv Nurs 2003; 43:465–477
140. Moffat N, Barker P, Pinkney L, et al: Snoezelen: An Experiencefor People With Dementia. Dorset: ROMPA, 1993
141. Cott CA, Dawson P, Sidani S, et al: The effects of a walking/talkingprogram on communication, ambulation, and functional statusin residents with Alzheimer disease. Alzheimer Dis Assoc Disord2002; 16:81–87
142. Reid DW, Tierney MC, Zorzitto ML, et al: On the clinical value ofthe London Psychogeriatric Rating Scale. J Am Geriatr Soc. 1991;39:368–371
143. Hersch EL, Kral VA, Palmer RB: Clinical value of the Londonpsychogeriatric rating scale. J Am Geriatr Soc 1978; 26:348–354
144. Frattali CM, Thompson CM, Holland AL, et al: The FACS of lifeASHA facs: a functional outcome measure for adults. ASHA 1995;37:40–46
145. Holmes C, Knights A, Dean C, et al: Keep music live: music andthe alleviation of apathy in dementia subjects. Int Psychogeriatr2006; 18:623–630
146. Sloane PD, Brooker D, Cohen L, et al: Dementia care mapping asa research tool. Int J Geriatr Psychiatry 2007; 22:580–589
147. Brooker D: Dementia care mapping: a review of the researchliterature. Gerontologist 2005; 45 11–18
148. Chung JC, Lai CK, Chung PM, et al: Snoezelen for dementia.Cochrane Database Syst Rev 2002; CD003152
149. Gilleard CJ, Pattie AH, Dearman G: Behavioural disabilities inpsychogeriatric patients and residents of old people’s homes. JEpidemiol Community Health 1980; 34:106–110
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
562 Am J Geriatr Psychiatry 20:7, July 2012
Brodaty and Burns
150. Greene JG, Smith R, Gardiner M, et al: Measuring behaviouraldisturbance of elderly demented patients in the community andits effects on relatives: a factor analytic study. Age Ageing 1982;11:121–126
151. Neville CC, Byrne GJ: Behaviour rating scales for older peoplewith dementia: which is the best for use by nurses? Australas JAgeing 2001; 20:166–172
152. Holtkamp C, Kragt K, Van Dongen M, et al: Effects of snoezelenon the behaviour of demented elderly. Tijdschr Gerontol Geriatr1997; 28:124–128
153. Verstraten PF: The GIP: an observational ward behavior scale.Psychopharmacol Bull 1988; 24:717–719
154. Bellelli G, Frisoni GB, Bianchetti A, et al: Special care unitsfor demented patients: a multicenter study. Gerontologist 1998;38:456–462
155. Lawton MP, Van Haitsma K, Klapper J, et al: A stimulation-retreat special care unit for elders with dementing illness. IntPsychogeriatr. 1998; 10:379–395
156. Helmes E, Csapo KG, Short JA: Standardization and validationof the Multidimensional Observation Scale for Elderly Subjects(MOSES). J Gerontol 1987; 42:395–405
157. Lawton MP, Van Haitsma K, Klapper J: Observed Emotion Rat-ing Scale [H:\jmarainen\Web site\OERS\OBSERVED EMOTIONRATING SCALE.doc], 1999
158. Lawton MP, Van Haitsma K, Klapper J: Observed affect in nursinghome residents with Alzheimer’s disease. J Gerontol B PsycholSci Soc Sci. 1996; 51B:3–14
159. Kolanowski AM, Litaker M, Buettner L: Efficacy of theory-basedactivities for behavioral symptoms of dementia. Nurs Res 2005;54:219–228
160. Colling KB: A taxonomy of passive behaviors in people withAlzheimer’s disease. J Nurs Scholarsh 2000; 32:239–244
161. Politis AM, Vozzella S, Mayer LS, et al: A randomized, controlled,clinical trial of activity therapy for apathy in patients with de-mentia residing in long-term care. Int J Geriatr Psychiatry 2004;19:1087–1094
162. Camberg L, Woods P, Ooi WL, et al: Evaluation of Simulated Pres-ence: a personalized approach to enhance well-being in personswith Alzheimer’s disease. J Am Geriatr Soc 1999; 47:446–452
163. Lai CKY, Chi I, Kayser-Jones J: A randomized controlled trial ofa specific reminiscence approach to promote the well-being ofnursing home residents with dementia. Int Psychogeriatr 2004;16:33–49
164. Byar DP, Simon RM, Friedewald WT, et al: Randomized clinicaltrials: perspectives on some recent ideas. N Engl J Med 1976;295:74–80
165. Schroll M, Jonsson PV, Mor V, et al: An international study ofsocial engagement among nursing home residents. Age Ageing.1997; 26:55–59
166. Mor V, Branco K, Fleishman J, et al: The structure of social en-gagement among nursing home residents. J Gerontol B PsycholSci Soc Sci. 1995; 50:1–8
167. Schrijnemaekers V, van Rossum E, Candel M, et al: Effects ofemotion-oriented care on elderly people with cognitive impair-ment and behavioral problems. Int J Geriatr Psychiatry 2002;17:926–937
168. Finnema EJ, Droes RM, Van der Kooij CH, et al: The designof a large-scale experimental study into the effect of emotion-oriented care on demented elderly and professional carers innursing homes. Arch Gerontol Geriatr 1998; 27:193–200
169. Feil N: Validation: techniques for communicating with confusedold-old persons and improving their quality of life. Top GeriatrRehabil 1996; 11:34–42
170. Samus QM, Rosenblatt A, Steele C, et al: The association of neu-ropsychiatric symptoms and environment with quality of lifein assisted living residents with dementia. Gerontologist 2005;45:19–26
171. Kasper JD, Black BS, Shore AD, et al: Evaluation of the validityand reliability of the Alzheimer Disease-related Quality of LifeAssessment Instrument. Alzheimer Dis Assoc Disord 2009; 23:275–284
172. Landes AM, Sperry SD, Strauss ME: Prevalence of apathy, dys-phoria, and depression in relation to dementia severity inAlzheimer’s disease. J Neuropsychiatry Clin Neurosci 2005; 17:342–349
173. Mittelman MS, Roth DL, Haley WE, et al: Effects of a caregiverintervention on negative caregiver appraisals of behavior prob-lems in patients with Alzheimer’s disease: results of a randomizedtrial. J Gerontol B Psychol Sci Soc Sci 2004; 59:27–34
174. Livingston G, Johnston K, Katona C, et al: Systematic review ofpsychological approaches to the management of neuropsychi-atric symptoms of dementia. Am J Psychiatry 2005; 162:1996–2021
175. Yap LK, Seow CC, Henderson LM, et al: Family caregivers andcaregiving in dementia. Rev Clin Gerontol 2005; 15:263–271
176. Lawlor B: Managing behavioural and psychological symptoms indementia. Br J Psychiatry. 2002; 181:463–465
177. Roth RM, Flashman LA, McAllister TW: Apathy and its treatment.Curr Treat Options Neurol 2007; 9:363–370
178. Sullivan FR, Bird ED, Alpay M, et al: Remotivation ther-apy and Huntington’s disease. J Neurosci Nurs 2001; 33:136–142
179. Walter M, Hanni B, Haug M, et al: Humour therapy in patientswith late-life depression or Alzheimer’s disease: a pilot study. IntJ Geriatr Psychiatry 2007; 22:77–83
180. Teri L, Rabins P, Whitehouse P, et al: Management of behaviordisturbance in Alzheimer disease: current knowledge and futuredirections. Alzheimer Dis Assoc Disord 1992; 6:77–88
181. Wu HZY, Low LF, Xiao S, et al: A pilot study of differences inbehavioral and psychological symptoms of dementia in nursinghome residents in Sydney and Shanghai. Int Psychogeriatr. 2009;21:476–484
182. Caputo M, Monastero R, Mariani E, et al: Neuropsychiatric symp-toms in 921 elderly subjects with dementia: a comparison be-tween vascular and neurodegenerative types. Acta PsychiatrScand 2008; 117:455–464
183. Ballard CG, Burgio KL, Burns A, et al: Discussion 8. Int Psy-chogeriatr 2000; 12:387–390
184. Cohen-Mansfield J: Nonpharmacologic interventions for inappro-priate behaviors in dementia: a review, summary, and critique.Am J Geriatr Psychiatry 2001; 9:361–381
185. Michel J-P, Gold G: Behavioural symptoms in Alzheimer’s dis-ease: validity of targets and present treatments. Age Ageing 2001;30:105–106
186. Burns A: Another nail in the coffin of the cognitive paradigm ofdementia. Br J Psychiatry 2009; 194:199–200
187. Aarsland D, Larsen JP, Lim NG, et al: Range of neuropsychiatricdisturbances in patients with Parkinson’s disease. J Neurol Neu-rosurg Psychiatry 1999; 67:492–496
188. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity,and clinical correlates of apathy in Parkinson’s disease. J Neu-ropsychiatry Clin Neurosci 1992; 4:134–139
189. Sockeel P, Dujardin K, Devos D, et al: The Lille apathy rating scale(LARS), a new instrument for detecting and quantifying apathy:validation in Parkinson’s disease. J Neurol Neurosurg Psychiatry2006; 77:579–584
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
Am J Geriatr Psychiatry 20:7, July 2012 563
Nonpharmacological Management of Apathy in Dementia
190. Withall A, Harris LM, Cumming SR: The relationship be-tween cognitive function and clinical and functional out-comes in major depressive disorder. Psychol Med 2009; 39:393–402
191. Bates J, Boote J, Beverley C: Psychosocial interventions for peo-ple with a milder dementing illness: a systematic review. J AdvNurs 2004; 45:644–658
192. Meiland FJMP, Kat MGMD, van Tilburg WPMD, et al: The emo-tional impact of psychiatric symptoms in dementia on part-ner caregivers: do caregiver, patient, and situation character-istics make a difference? Alzheimer Dis Assoc Disord 2005; 19:195–201
193. Alexander MP, Stuss DT: Disorders of frontal lobe functioning.Semin Neurol 2000; 20:427–437
194. Volicer L: Can dietary intervention help in management ofproblem behaviors in dementia? J Nutr Health Aging 2009; 13:499–501
195. Richeson NE: Effects of animal-assisted therapy on agitated be-haviors and social interactions of older adults with dementia. AmJ Alzheimer’s Dis Other Dement 2003; 18:353–358
196. Ayalon L, Gum AM, Feliciano L, et al: Effectiveness of nonpharma-cological interventions for the management of neuropsychiatricsymptoms in patients with dementia: a systematic review. ArchIntern Med 2006; 166:2182–2188
197. Kolanowski AM, Buettner L, Costa PT Jr, et al: Capturing inter-ests: therapeutic recreation activities for persons with dementia.Ther Recreation J 2001; 35:220–235
198. Galik E, Resnick B, Pretzer-Aboff I: ‘Knowing what makes themtick’: motivating cognitively impaired older adults to participatein restorative care. Int J Nurs Pract 2009; 15:48–55
199. Zetteler J: Effectiveness of simulated presence therapy for indi-viduals with dementia: a systematic review and meta-analysis.Aging Ment Health. 2008; 12:779–785
200. Kitwood T, Bredin K: Towards a theory of dementia care: per-sonhood and well-being. Ageing Soc 1992; 12:269–287
201. Finnema E, Droes RM, Ettema T, et al: The effect of integratedemotion-oriented care versus usual care on elderly persons withdementia in the nursing home and on nursing assistants: a ran-domized clinical trial. Int J Geriatr Psychiatry 2005; 20:330–343
202. Small GW, Rabins PV, Barry PP, et al: Diagnosis and treatmentof Alzheimer disease and related disorders. Consensus state-ment of the American Association for Geriatric Psychiatry, theAlzheimer’s Association, and the American Geriatrics Society.JAMA 1997; 278:1363–1371
203. Verkaik R, van Weert JCM, Francke AL: The effects of psychoso-cial methods on depressed, aggressive and apathetic behaviorsof people with dementia: a systematic review. Int J Geriatr Psy-chiatry 2005; 20:301–314
Copyright © American Association for Geriatric Psychiatry. Unauthorized reproduction of thisarticle is prohibited.
564 Am J Geriatr Psychiatry 20:7, July 2012